Tapering antipsychotics: how it's done safely

For decades, the standard advice for someone considering coming off an antipsychotic was either "do not" or "do it over a few weeks." Both extremes have aged poorly. Research and clinical experience have moved toward a third position: in carefully selected patients, with a slow, structured taper and a good safety net, dose reduction or discontinuation is reasonable to attempt — and the way it is done matters more than people realize.

When tapering is reasonable to consider

There is no universal rule, but most clinicians look for several conditions before discussing a taper:

• The patient is psychiatrically stable — typically at least 1–2 years for first-episode patients, longer for those with multiple episodes
• The patient has a treatment relationship with a prescriber and is willing to continue it through the taper
• There is a workable plan for early warning sign monitoring and rapid re-engagement of treatment
• The motivation for tapering is clear — side effect burden, patient preference, life circumstance
• There is no recent crisis (suicide attempt, hospitalization, severe relapse)

Even when these are met, tapering carries real relapse risk. The RADAR trial in the UK, one of the largest tapering studies in non-acute schizophrenia, found that gradual antipsychotic dose reduction was associated with higher relapse and admission rates than maintenance treatment over 2 years, although some patients did achieve sustained reduction. The takeaway is not "never taper" — it is "go in with eyes open."

Why "slow" means slower than you think

The traditional approach was linear: drop the dose by a fixed amount every few weeks. The newer approach, drawing on receptor occupancy data, is hyperbolic. Dopamine D2 receptor occupancy does not decrease linearly with dose. At higher doses, dropping by 5 mg of olanzapine barely changes receptor occupancy. At lower doses, the same 5 mg drop can change occupancy substantially. The implication: the closer you get to zero, the smaller and slower the steps need to be.

A common practical pattern:

• Reduce by no more than 10–25% of the current dose per step
• Wait at least 4–8 weeks at each new dose to assess stability
• Slow further as you approach lower doses
• The whole process often takes 6–24 months — sometimes longer

How to set up a taper plan

1. Pick a stable window

Avoid starting a taper during major life stress, a job change, a move, or a relationship transition. Stability tends to attract stability.

2. Document baseline

Before reducing, write down current symptoms, sleep, mood, energy, social functioning. Most relapses begin with subtle changes that are easy to miss without a baseline.

3. Build the early warning sign list

From past episodes, list what came first. Sleep loss? Increased suspicion? Withdrawal from friends? See our early warning signs guide. Share this list with at least one trusted person.

4. Schedule check-ins

Plan regular contact with the prescribing team. Many tapers benefit from monthly visits during the active reduction period.

5. Define the "go back" plan

Decide in advance what specific events would trigger a return to a higher dose. Writing it down before symptoms start protects against later denial.

What can go wrong

Withdrawal symptoms

Dizziness, nausea, sweating, insomnia, anxiety, and restlessness can appear in the first weeks after a dose reduction. These are usually transient and often resolve within 2–4 weeks. They are different from a return of the underlying psychotic illness — see our antipsychotic withdrawal article.

Rebound psychosis

Sometimes psychotic symptoms return more intensely than they were before the original treatment, particularly with rapid discontinuation of high-affinity D2 blockers. This is one of the strongest arguments for slow tapers.

Withdrawal dyskinesia

Involuntary movements that emerge or worsen as the antipsychotic is reduced. They sometimes resolve, sometimes persist, and can be confused with tardive dyskinesia.

Relapse

The biggest risk. Relapse rates after antipsychotic discontinuation in schizophrenia are high — most studies report 60–80% within 1–2 years off medication. Slower tapers reduce but do not eliminate this risk.

What about long-acting injections?

Tapering long-acting injectables (LAIs) is a slightly different process. The medication is released slowly over weeks, so dose reductions are made by lengthening the interval, lowering the injected dose, or both. The pharmacokinetic "tail" provides some cushion against rapid drops in plasma level. See LAI vs oral antipsychotics.

The cultural shift

Ten years ago, asking your psychiatrist about tapering was sometimes met with a flat refusal. The conversation has changed. Both NICE guidelines and the APA guideline for schizophrenia now explicitly support shared decision-making about long-term medication, including discussions of dose reduction. Patients have the right to ask the question. Prescribers have a responsibility to engage with it honestly — including with the data on relapse risk.

Practical questions to ask your prescriber

• Given my history, what do you think the relapse risk is over the next 1–2 years if I taper?
• What dose-reduction pace would you propose?
• How will we monitor early warning signs?
• What is our plan if symptoms come back?
• Could we try a dose reduction first, before considering discontinuation?

The big picture

Tapering an antipsychotic is a real choice that some patients can make safely, especially with a slow schedule, a strong support system, and a clear plan. It is not for everyone, and it is not without risk. The right answer for any individual depends on illness history, current stability, side effect burden, and personal goals. The conversation belongs in the office, with a prescriber who knows your full story, not on the internet — including this article.

For related reading, see antipsychotic discontinuation, relapse prevention planning, and shared decision-making.

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.